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Endotheliaim plays a major ole in the control of vasomotor 
tone through the release of fact’ors t at induce vasodi~at~o~ 
and contraction (I-3). Acetylcholine has been shown to 
cizse n;ld&e!lm -dependent hressel relaxation (1) in aai- 
mals and in humans (4,5), and several human studies bave 
demonstrated that acetylcholine produces vasodilatinp C$ 
normal epicardial coronary arteries and constriction of dis- 
eased vesseis (6--X!). Ahnormal e~dothelium-dependent 
vasodilator res;ranses can occur very eariy &r trasqplan- 
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tation (11). and reiativeiy few a~giogra~hica~~y no 
onary arteries n tran “eant recipients at i2 and 2 
after transp~aotatio~ late iv1 response to acety~cbo~a~ 
infusion (12). Because accelerated coronary artery disease is
the main determinant of long-term pro 
recipients (I$, and because ndotheliu 
target of cardiovascular disease (3), it 
that either early endothelial dysfimction might be invoked in 
the development of accelerated atherosclero 4) or ath- 
eroscicrssis pnt detectable by an~iogra~b~ ops early 
after surgery. 
The aim of the present study was to co 
onses of a~giogra~bical~y normal corona 
stepwise i~tracoronary infusion cf acetyl 
plant recipients 1 month postoperatively an 
12 and >24 months postoperatively to vai 
appearance of acety~ch~i~~e-induced vas 
sults obtained in four groups of patients without rejection 
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Table 1. Study Group Characteristics 
Control 
Subjects Group 1 Group 2 Group 3 Group 4 
(n = 5) (n = 6) (n = 7) (n = 6) (n = 6) 
Age (yr) 35.4 rt 1.9 46.0 + 5.4t 57.3 2 5s 56.1&6$ 51 7 -c 9.4$ 
r p < 0.01 _--I 
L p < 0.05 .I 
MaleNemaie 411 5/l 512 610 610 
Heart transp:iant age (yr) - 31.3 2 12.3 34.4 f 14.3 29.8 c 14.9 33.5 f 6.1 
Duration of ischemia (mitt) - 163 2 40 109 + 20 170 c 59 132 f 35 
L__p<0.01_.__/ L__p<0.05.___J 
No. of rejection eprsodes/no. of pts. 1.2 ?. 0.8 3.3 f 1.4 3.3 + 1.6 2.5 + 1.2 
I 
0.05 1 
HR (beatslmin) 8426 85 2 7 85 + 9 83 + 8 81 ? 13 
LVSP (mm Hg) 119 c IO 136 + 16 147 141 2 22 125 k 15 
p < 0.05 .---_--1 
LVEDP (mm Hg) 8~2 13 ?I 7 II 23 10 + 5 124 
MAP (mm Hg) 87 r 4 104 + lot 111 * 9* 110 + 14t 106 + 14 
LVBDV (mUmz) 822 II 81 k 13 79 2 10 83 ?z 13 732 11 
RF (%I 69 f 5 67 rt 9 M*g 68 + 5 67 2 7 
LVM (gIm*) 86 !z to 75 zk 14 84 r 7 20 82 ? 9 
I_ p c 0.05 
Total cholesterol (mmobliter) 5.28 + 0.53 5.50 + 0.38 5.58 f 0.92 6.10 + 1.13 6.02 c 1.19 
Trialycetides (mmoPliter) 1.26 f 0.31 1.35 f ii.24 1.61 + 0.46 2.36 -f t.:15 1.98 + 0.50 
*p < 0.05; tp < 0.01; $p < O.&l vows control subjects. Data are expressed as number of patients or mean value t SD. EF = ejection fraction; Groups I 
to 4 indicate, respectively, patients 1, 6, 12 and >24 months after heart transplantation. HR = heart rate: LVEDP = left ventricular end-diastolic pressure: 
LVEDV = left ventricular end-diastolic volume; LVM = left ventricular mass; LVSP = left ventricular systolic pressure: MAP = mean aortic pressure: ptb = 
patients. 
were compared with those of a group of young control 
subjects. 
htient sekction. Control subjects (Table I). Five young 
patients were selected as control subjects. All had angio- 
graphically normal coronary arteries without lumen irregu- 
larities. They were referred for diagnostic coronary arteriog- 
raphy because of repetitive atypical chest pain syndromes 
and equivocal results of exercise treadmill tests or thallium 
scan scintigraphy, or both. All subjects were normotensive, 
and none had diabetes mellitus or hypercholesterolemia 
(Table 1). Left ventricular two-dimensional and M-mode 
echocardiographic findings were normal (diastolic septal and 
posterior wall thickness <lo mm, normal cavity dimensions 
and normal systolic performance). Nosubject was receiving 
any cardiovascular therapy at the time of investigation. 
Transplant recipients. Among 3 I consecutive patients 
who had previously undergone cardiac transplantation, 25 
were included in the study. All had normal findings on 
two-dimensional and M-mode chocardiography. Coronary 
arteries were angiographically normal without lumen irreg- 
ularities. Right ventricular endomyocardial biopsy per- 
formed the day of the investigation did not evidence any sign 
of rejection. These patients were classified into four groups 
according tothe interval after heart ransplantation: group 1, 
erativdy; group 2, seven patients 
6 months postoperatively; group 3, six patients 12 months 
postoperatively; group 4, six patieuts >24 months postoper- 
atively [38.8 + 16.8 months (mean f: SD), range 24-701. 
Among the 31 selected patients, no patient was excluded in 
groups 1 and 2, but 2 of 8 in group 3and 3 of 10 in group 4
were excluded from the study because of coronary lumen 
irregularities (n = 3) or stenosis (n = 2). Posttransplantation 
immunosuppressive therapy comprised prednisone and cy 
closporine inall patients. Cyclosporine was titrated to main- 
tain serum levels between 150 and 200 @ml during the 1st 
year after transplantation and 100 to 200 ng/ml thereafter, as
measured by nonspecific radioimmunoassay (S nd&. Other 
treatments are depicted in Tabble 2. 
All studies were approved by the local institutional hu- 
Table 2. Treatments Other Than Cyclosporine and Prednisone 
Received in Each Group of Transplant Recipients 
Group 1 Group 2 tiroup 3 Group 4 
Azathioprine 4 5 1 1 
Acebutolol I I 1 1 
Kicardipine 0 0 0 4 
Praxosin 2 0 1 0 
Furosemide I 3 0 0 
Groups as delined in ‘Table 1. Data indicate number of patients. 
caine was used for 
local anesthesia, and 5 
was a 
the left coronary arte 
dissolved in warmed 
ages were used to achieve the estimate 
tions of 1OP, 10-7, KP a 
coronary circulation assumin 
nant right coronary artery (IS). The infusion rate was 
1 mUmin d~~~~g 5 min for each c~~ce~tra~i~~. Last, 3mg of 
isosorbide dinitrate was administered bythe left coronary 
2rtenr -__ ._,. After esch dose of acctylcboline and after isosorbide 
dinitrate, coronary arteriogra~by was perfor 
ately (10 to 15 s r stopping the infus 
withdrawal of the 
nary device. Core arter~ograms were 0 
tion of 8 ml of meg~~mine ioxaglate. Arterial pressure, heart 
rate and the lectrocardiogram (ECG) were monitored co 
tinuously throughout the protocol. 
y a~a~ys~~ Left ventricular 
an a 30” right anterior oblique 
projection (30 ml ofioxaglate meglumine ata rate of 12 ml/s). 
Left ventricular end-diastolic and end-systolic volumes and 
ejection fraction were calculated by the area-length method 
(16). Left ventricular mass was cakulded by the method of 
Rackley et al. (17) using wall thickness measured atend- 
diastole at the equator of the left ventricle. All measures 
were obtained after correction of X-ray magnification. 
~a~t~~a~~ve c r~~a~~ ang~ogra~~y. Right and left 
arteriograms in multiple projections were obtain 
KG-triggered igital subtraction ai a rate of 6 frames/s on a 
513pixel matrix (General Electric CGR DG 3W. Angio- 
grams were examined by two experienced investigators, and 
only patients with smooth vessels were included in the 
study. The angiographic system was then set 
antceor oblique position, with adequate cranial or raudal 
angulation allowing analysis of the left artetial tree on 
end-diastole frames without overlap of coronary segments. 
s~reme~~s wer 
calibration. The mean dia 
coronary segment from a s 
magnification factor taking into account the 
segment from the center of the image. Res 
ysis. All values are expres 
authorized, comparisofis between two groups were per- 
formed with a two-tailed unpaired i’ test. Statis 
isons between responses to serial doses ofacet 
to isosorbide dinitrate 
repeated measures. If 
Bonferroni correctlo 
icance level according to the arison umber. Statistical 
dirdference was assumed if tke ouH hypoihesis Cdd be 
rejected at the 0.05 probability Level. 
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Study group characteristics. The age of the transplanted 
hearts in each group was similar to that of the control 
subjects. The duration of iscbemia of the donor heart was 
significantly lower (6 months after operation) in group 2 than 
in groups 1 and 3 (1 month and 12 months, respectively, after 
operation), and average number of rejection episodes per 
patient was lower in group 1 than in groups 2 and 3. Left 
ventricular systolic pressure in group 2 and mean aortic 
pressure in groups I to 3 were higher than in the control 
group. End-diastolic volumes, ejection fraction and mass 
were similar in the transplant groups and control subjects. 
Systemic hemdynsmic responses. Intracoronary acetyl- 
choline infusion did not induce any chest pain or ECG signs 
of ischemia in control subjects and in transplant recipients. 
At IO-’ mollliter acetylcholine estimated concentration, five 
patients had a slower heart rate, resulting inright ventricular 
pacing (one control subject, wo patients ingroup I, none in 
group 2, one in group 3 and one in grotip 4 [>24 months after 
operation]), and mean aortic pressure decreased by 6.4 -t 
2.1% in the control group (p < O.Ol), by 7.1 -+ 2.8% in 
group 1 (p < O.Ol), by 4.7 + 3.1% in group 2 (p < 0.05), by 
5.4 -c 2.1% in group 3 (p < 0.01) and by 6.0 + 2.7% in 
group 4 (p < 0.01). 
Isosorbide dinitrate infusion significantly increased heart 
rate by 4.7 2 2.4% (p < 0.05) in control subjects, but heart 
rate was not significantly modified in all transplant groups. 
Mean aortic pressure r mained lower than the basal value in 
control subjects (-3.5 1 2.2%: p < 0.05) and in transplant 
recipients (-4.8 + 3.1 in group I, p < 0.05; -5.1 + 1.9% in 
group 2, p < 0.01; -3.7 * 1.4% in group 3, p < 0.01, and 
-4.3 ? 1.7% in group 4. p < 0.01). 
Diameter responses of epicardia! coronary art&s. Con- 
troi subjects. Stepwise infusion of acetylcholine produced 
progressive dilation of coronary arteries from estimated 
concentrations of 10V8 to 10m6 mollliter (Fig. 1). No signif- 
icant variation was observed atIO-’ mollliter. lntracoronary 
isosorbide dinitrate increased the diameter of all segments 
(Fig. 1). When only diameter variations >6% were consid- 
ered, acetylcholine did not produce constriction on a y of 
the 20 segments analyzed from estimated concentrations of 
lob8 to 10m6 moyliter. A majority of segments evidenced no
change at IO-* moUliter; most dilated at 10S7 and 10T6 
mOl/hr. Conversely, an estimated concentration of 10e5 
molkter of acetylcholine produced no change or constriction 
but no dilation (Fig. 2). Constriction, when it occurred, MS 
diffuse in all control subjects. 
Transplant recipients. The dose-response r lation to a 
stepwise infusion of acetylcholine i  at! groups of transplant 
recipients with progressive r duction in lumen diameter 
(Fig. 1) was strikingly different from that in the control 
fWuP. More precisely, vessel diameters did not vary signif- 
icantly from baseline for estimated concentra;ions of IO-* 
and 10S7 moVliter in groups I and 3 and for lo-* molfiiter in 
WUP 4. VesSdS constricted significar:tly !n all other pa- 
Figure 1. Plots of change in coronary segment diameters expressed 
as percent of base (mean + SD) in response to increasing concen- 
trations of acetylcholine (Ach), and isosorbide dinitrate (ISDN). 
*p < 0.05; **p i 0.01; ***p < 0.001 versus base (intragroup 
comparisons). Numbers epresent results of comparisons among the 
four groups of transplant recipients (HTX) and control subjects for 
each acetylcholine concentration. M = moi/liter. 
tients. Comparisons of each group of transplant recipients 
with control subjects howed that responses were signifi- 
cantly diiferent for ail acetylcholine concentrations except 
lOa molAiter in groups 3 and 4. Constriction, when it 
occurred, was diffuse in all patients, but areas of focal 
constriction were observed inone of six patients in groups li
and 3 and in three of six patients ingroup 4. Conversely, 
intracoronary isosorbide dinitrate licited coronary vasodi- 
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coronary segment responses expressed a 
cQ~ce~~~a~~~~ in sonbrol 
died, respectively. I, 6, 12 
= mol/liter. 
n group 2 for concen- 
analyzing the prevalence ofeach type of response (duration, 
rro chartge or constriction), it can be seer-r that an increasing 
proportion of segments corastricted from estimated concen- 
trations of 10-a to 1OP be t~a~s~~a~t groups, 
whereas tro segment cons 
an estimated co~ce~trat~o~ o 
segments constricted in transplant recipiems (Fig. 2). 
Recause injury to endothelium is known to be a determi- 
nant itr the development of atherosclerosis (18, and because 
alterations in endothelial vasoactive fuunction may be impor- 
tant in the development of c ronary atherosclerosis in trans- 
plant recipients (14), aiterations in coronary vasodilator 
response to acetylcholine have been proposed to assess 
coronary endothelial function in SN$ recipients to detect 
early atherosclerosis. Our study FLOWS that acety~cho~~~e- 
induced coronary vasoconstrictiou ccurs as early as 1 
month postoperatively and th t here is no improvement or 
deierioralion i the response 6, 12 and >24 months after 
~a~~atio~ in pafk,rrts with normal 
suggesting that acety~cho~ine~-~nduc 
dilation is impaired early after tra~sp~a~tatioo nd is not 
affected by the time: lapsed after the procedure. Because dI
rs) (13,14,32). conversely, 
091 within the 1st year after 
proposed that acety~cho~ine-~~dMced coronaryconst~ctio~ 
could predict he development of atherosclerosis (12) 
oor chnical olatcome (36); however, intra~s~~a~t recipi 
by I to 8 years after traosp~a~tatio~ w thout any angio- 
graphic evidence of coronary artery disease, acety~cho~i~e 
failed to dilate or it induced epicardia! coronary vasocon- 
striction (12,37). T e response was diffuse in 
and focai ra some (12). In our study, simila 
obtained inearly (1 to 4 
sence of coronary 
of e~dotbel~um-delved relaxing factor or factors (1,4,5). 
Bostischemic impairment of coronary vasodi~at~o~ iu 
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group I patients might be questioned because hypoxia or 
anoxia inhibits the release of enl?othelial-derived relaxing 
factor and stimulates the release of endothelial-derived con-
tracting factor <41,42) and because ischemia induces Pro- 
longed alterations in endothelium (43) that may impair 
normal endothelium-dependent relaxation (43-45); however, 
normal response toacetylcholine should have been restored 
in group 2 (6 months after operation) (46). Atherosclerosis of 
donor heart transplants (45) is probably not involved in 
patients at I month because the mean age of donor hearts 
was low and not different from that in the control group 
(Table 1); however, intimal thickening has been shown by 
intracoronary ultrasonography even in patients examined i 
month postoperat:vely (48). However, intimal thickening 
was minimal (co.30 mm) in all patients and in patients with 
normal coronary arteriograms examined after 1 year (48). 
Conversely, in another study (49), 65% of coronary sites had 
normal intimal thickness at I year. All of these results are to 
be compared with the absence of coronary dilation in any 
segment a an acetylcholine concentration f IO-” moilliter 
in our groups 1 and 2 (1 and 6 months, respectively, after 
operation) (Fig. 2). Hypercholesterolemia and high levels of 
low density lipoprotein in the transplant recipients could 
explain acetylcholine-induced oronary vasoconstriction 
(28). Although low density bpoprotein levels have not been 
deter-mined in the study group, similar responses to acelyl- 
choline infusion were observed intransplant recipients with 
low levels of total cholesterol or triglycerides (six and nine 
patients, respectively) than in patients with high levels (nine 
and eight patients, respectively) (Fig. 3). In addition, abnor- 
mal vasodilator responses to acetylcholine tiue to hyperten- 
sion (30) might be involved in some patients {one in group 1, 
two in group 2, one in group 3 [12 months after operation]) 
but not in normotensive patients. Finally, another potential 
factor of constriction might be cyclosporine itself. Cyclospo- 
rine stimulates synthesis of endothelia by endothelial cells 
(50) and has been shown to increase endothelin binding sites 
in cardiac smooth muscle cells (51). In addition, cyclospo- 
tine elicits cell membrane disruption, diminishes prostacy- 
chn synthesis by vascular endothelial cells (52,53) and en- 
hances thromboxane AZ release (54). Thus, cyclosporine 
may be involved in acetylcholine-indticed paradoxic coro- 
nary vasoconstriction by several mechanisms. 
In contrast to acetylcholine, intracoronary infusion of 
substance P, i\ potent endothelium-derived relaxing factor- 
mediated coronary vasodilator without direct action on 
smooth muscle cells (55), has been demonstrated to evoke
normal epicardial coronary vasodilation independently from 
the time elapsed after transplantation, suggesting normal 
endothelial synthesis and release of endothelium-derived 
rehNing factor and normal coupling between endothebal and 
smooth muscle cells (56). The discrepancies between these 
two endothelium-derived relaxing factor-mediated coronary 
vadilators are probably due to the ffects of acetylcholine 
on both endothelia1 nd vascular myocyte muscarinic recep- 
tors. Thus, acetylcholine-induced s:onary constriction 
Figure 0” Plsts of change in coronary segment diameters expressed 
as percen! of base (mean + SD) in response to increasing concen- 
trations of acetylcholine (A&) and isosorbide dinitrate (ISDN) in 
patients with high and low levels of total cholesterol or triglycerides. 
Similar responses to stepwise infusion of acetylcholine were ob- 
served in each group. I = liter; Iv! = mollliter. 
could result either from an alteration in endothehal receptor 
response to acetylc oline or from a diseq~ii~bri~m between 
endothehal and vascular myocyte receptors or from differ- 
ential receptor-G protein coupling of these agonists (57), 
altering the normal interplay between direct vasoconstric- 
tion and endothelium-derived relaxing factor-mediated va- 
sodilation. 
~e~~~o~ogic consi The method of quantifica- 
tion of coronary artery dimensions assumes that the refer- 
ence catheter (the pacing catheter) and vessel segments are
located in the same plane parallel to the detector. This 
assumption is not absolutely true in that the pacing catheter 
is positioned in the right ventricle; however, only relative 
variations in coronary artery dimensions were used in this 
study. 
The effects of acetylcholine onhuman coronary rteries 
are still controversial (10.5859). It has been demonstrated 
that lower doses of acetylcholine induce vasodilation and 
that higher doses induce vasoconstriction (7), suggesting tbat 
higher concentrations produce direct smooth muscle con- 
traction that override the indirect effect due to release of 
endothelium-derived relaxing factor. Left caronary blood 
flow was assumed tobe normai in all transplant recipients, 
and values were used to determine the rate of acetylcholine 
infusion. Because l ft ventricular function was not altered, 
coronary blood flow should be at least within normal range: 
however, in patients with elevated heart rate or arterial 
of basal rate. No 
of epicardial coronary 
acetylchohne may not be a useful tool 
rent times after opera- 
n stre~gtbe~ed ha  our 
C~nc~~s~o~s~ In transplant recipients with normal coro- 
nary arteriograms and without tr plant rejection, coronary 
artery cholinergic vasodilator ec~a~isms are impaired 
early after operation and ar imilarly altered at ail 
subsequent times. Although it has been suggested that the 
paradoxic response to acetylcholine may be mediated by 
endothehal dysfunction a d failure of release ofe~dQtbe~~~rn- 
factor in atherosclerosis (25), the present 
at the acetylch~~i~e respcmse is persistentty 
abnormal in transplarmt ecipients red with that iw normal 
control subjects and that this d ce may not be related 
simply to the presence o~atber~sc~er~sis. Zra ddition, because 
in transplant recipients, several mechanisms could be involved 
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